Morgan Stanley Inspire Medical Systems, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Morgan Stanley holds 363,307 shares of INSP stock, worth $67.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

363,307

Previous 257,376 41.16%

Holding current value

$67.4 Million

Previous $34.4 Million 122.61%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$125.79 - $216.71 $13.3 Million - $23 Million	105,931 Added 41.16%	363,307 $76.7 Million
Q2 2024 Oct 17, 2024	BUY	$133.83 - $251.19 $16.2 Million - $30.3 Million	120,805 Added 88.46%	257,376 $34.4 Million
Q2 2024 Aug 14, 2024	BUY	$133.83 - $251.19 $16.2 Million - $30.3 Million	120,805 Added 88.46%	257,376 $34.4 Million
Q1 2024 Oct 17, 2024	SELL	$165.3 - $226.0 $20 Million - $27.3 Million	-120,805 Reduced 46.94%	136,571 $29.3 Million
Q1 2024 Aug 16, 2024	SELL	$165.3 - $226.0 $6.11 Million - $8.36 Million	-36,992 Reduced 21.31%	136,571 $29.3 Million
Q1 2024 May 15, 2024	SELL	$165.3 - $226.0 $6.11 Million - $8.36 Million	-36,992 Reduced 21.31%	136,571 $29.3 Million
Q4 2023 Aug 16, 2024	SELL	$125.26 - $203.83 $10.5 Million - $17.1 Million	-83,813 Reduced 32.56%	173,563 $35.3 Million
Q4 2023 Feb 13, 2024	BUY	$125.26 - $203.83 $6.11 Million - $9.95 Million	48,816 Added 39.13%	173,563 $35.3 Million
Q3 2023 Nov 15, 2023	SELL	$185.0 - $326.08 $12.1 Million - $21.4 Million	-65,661 Reduced 34.48%	124,747 $24.8 Million
Q2 2023 Aug 14, 2023	BUY	$226.52 - $324.64 $2.04 Million - $2.92 Million	8,991 Added 4.96%	190,408 $61.8 Million
Q1 2023 May 15, 2023	BUY	$229.06 - $278.01 $11.6 Million - $14.1 Million	50,627 Added 38.71%	181,417 $42.5 Million
Q4 2022 Feb 14, 2023	BUY	$164.02 - $259.76 $2.25 Million - $3.57 Million	13,727 Added 11.73%	130,790 $32.9 Million
Q3 2022 Nov 14, 2022	SELL	$170.68 - $226.46 $5.6 Million - $7.43 Million	-32,817 Reduced 21.9%	117,063 $20.8 Million
Q2 2022 Oct 27, 2022	BUY	$147.53 - $266.6 $3.34 Million - $6.03 Million	22,625 Added 17.78%	149,880 $27.4 Million
Q2 2022 Aug 15, 2022	BUY	$147.53 - $266.6 $3.34 Million - $6.03 Million	22,625 Added 17.78%	149,880 $27.4 Million
Q1 2022 Oct 27, 2022	SELL	$193.94 - $261.91 $4.39 Million - $5.93 Million	-22,625 Reduced 15.1%	127,255 $32.7 Million
Q1 2022 May 13, 2022	SELL	$193.94 - $261.91 $6.79 Million - $9.16 Million	-34,990 Reduced 21.57%	127,255 $32.7 Million
Q4 2021 Feb 14, 2022	SELL	$207.57 - $280.17 $22.3 Million - $30.1 Million	-107,604 Reduced 39.88%	162,245 $37.3 Million
Q3 2021 Nov 15, 2021	BUY	$170.0 - $258.58 $45.9 Million - $69.8 Million	269,849 New	269,849 $62.8 Million

Others Institutions Holding INSP

# of Institutions

397

Shares Held

27.5M

Call Options Held

519K

Put Options Held

590K

View Full List

About Inspire Medical Systems, Inc.

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $5.34B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

More about INSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account